The role of ultrasound examination for early identification of lymph-node metastasis of cutaneous squamous cell carcinoma: results from a single institutional center.


Journal

Italian journal of dermatology and venereology
ISSN: 2784-8450
Titre abrégé: Ital J Dermatol Venerol
Pays: Italy
ID NLM: 101778002

Informations de publication

Date de publication:
08 2021
Historique:
pubmed: 6 12 2019
medline: 26 10 2021
entrez: 6 12 2019
Statut: ppublish

Résumé

Metastasis from cutaneous squamous cell carcinoma (cSCC) mainly involve the regional nodal basin, with an incidence ranging from 2-4% until 15% in case of high-risk tumors. When dealing with high-risk cSCC, ultrasound examination is recommended every 3-4 months during follow-up. We aimed to determine the role of US examination in the early diagnosis of nodal metastasis from cSCC. We conducted a retrospective cohort study enrolling consecutive cases of histopathologically verified cSCCs from January 2007 to March 2018. All the enrolled cases were followed for at least one year and all cases of histopathologically verified metastasis were registered. We also reported if ultrasound of the regional basin was performed between the primary diagnosis and metastasis and how the latter was identified, through ultrasounds or clinically. A Kaplan-Meier survival analysis was conducted on patients undergoing ultrasounds during follow-up. A total of 1881 cases, belonging to 1441 patients were included. Thirty-one cases of nodal metastasis diagnosed after the primary tumor, in as many patients, were identified. All of the selected metastasis derived from high-risk primary cSCCs. Only in 19 cases ultrasound examination was performed during follow-up; of these, 10 were diagnosed through ultrasounds and 9 clinically. Survival analysis demonstrated that the time interval between primary tumor and metastasis was significantly lower for patients with metastasis diagnosed by ultrasounds than clinically (P=0.036). Our study highlighted the need to optimize the use of nodal ultrasound examination for high-risk cSCCs in order to early detect metastasis.

Sections du résumé

BACKGROUND
Metastasis from cutaneous squamous cell carcinoma (cSCC) mainly involve the regional nodal basin, with an incidence ranging from 2-4% until 15% in case of high-risk tumors. When dealing with high-risk cSCC, ultrasound examination is recommended every 3-4 months during follow-up. We aimed to determine the role of US examination in the early diagnosis of nodal metastasis from cSCC.
METHODS
We conducted a retrospective cohort study enrolling consecutive cases of histopathologically verified cSCCs from January 2007 to March 2018. All the enrolled cases were followed for at least one year and all cases of histopathologically verified metastasis were registered. We also reported if ultrasound of the regional basin was performed between the primary diagnosis and metastasis and how the latter was identified, through ultrasounds or clinically. A Kaplan-Meier survival analysis was conducted on patients undergoing ultrasounds during follow-up.
RESULTS
A total of 1881 cases, belonging to 1441 patients were included. Thirty-one cases of nodal metastasis diagnosed after the primary tumor, in as many patients, were identified. All of the selected metastasis derived from high-risk primary cSCCs. Only in 19 cases ultrasound examination was performed during follow-up; of these, 10 were diagnosed through ultrasounds and 9 clinically. Survival analysis demonstrated that the time interval between primary tumor and metastasis was significantly lower for patients with metastasis diagnosed by ultrasounds than clinically (P=0.036).
CONCLUSIONS
Our study highlighted the need to optimize the use of nodal ultrasound examination for high-risk cSCCs in order to early detect metastasis.

Identifiants

pubmed: 31804052
pii: S0392-0488.19.06487-3
doi: 10.23736/S2784-8671.19.06487-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

479-483

Auteurs

Riccardo Pampena (R)

Centro Oncologico ad Alta Tecnologia Diagnostica, AUSL - IRCCS Reggio Emilia, Reggio Emilia Italy - riccardopampena@gmail.com.

Margherita Raucci (M)

Centro Oncologico ad Alta Tecnologia Diagnostica, AUSL - IRCCS Reggio Emilia, Reggio Emilia Italy.

Marica Mirra (M)

Centro Oncologico ad Alta Tecnologia Diagnostica, AUSL - IRCCS Reggio Emilia, Reggio Emilia Italy.

Mara Lombardi (M)

Centro Oncologico ad Alta Tecnologia Diagnostica, AUSL - IRCCS Reggio Emilia, Reggio Emilia Italy.

Simonetta Piana (S)

Unit of Pathology, AUSL - IRCCS Reggio Emilia, Reggio Emilia, Italy.

Athanassios Kyrgidis (A)

First Department of Dermatology, Aristotle University, Thessaloniki, Greece.

Francesca Peccerillo (F)

Unit of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Alessia Paganelli (A)

Unit of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Federico Garbarino (F)

Unit of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Giovanni Pellacani (G)

Unit of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Caterina Longo (C)

Centro Oncologico ad Alta Tecnologia Diagnostica, AUSL - IRCCS Reggio Emilia, Reggio Emilia Italy.
Unit of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH